Thus, our data reveal a novel TNF-α/NF-κB/YY1/miR-10a/NF-κB regulatory circuit in RA FLSs that contributes to the autoamplification of inflammatory responses of RA, thus providing a novel potential diagnostic and therapeutic target for the treatment of RA. This evidence concerns the gene YY1 and rheumatoid arthritis.